CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
| CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
|---|---|---|---|---|---|---|
| C21804 | BRD-K61033289 | BRD-K61033289 | -- | -- | 15-delta-prostaglandin-j2 | Details |
| C21805 | BRD-K61034310 | BRD-K61034310 | -- | -- | -- | Details |
| C21806 | BRD-K61036791 | rucinol | TYR | Tyrosinase inhibitor | -- | Details |
| C21807 | BRD-K61039403 | BRD-K61039403 | -- | -- | -- | Details |
| C21808 | BRD-K61044449 | BRD-K61044449 | -- | -- | -- | Details |
| C21809 | BRD-K61045425 | BRD-K61045425 | -- | -- | -- | Details |
| C21810 | BRD-K61045941 | BRD-K61045941 | -- | -- | -- | Details |
| C21811 | BRD-K61048996 | BRD-K61048996 | -- | -- | -- | Details |
| C21812 | BRD-K61050052 | BRD-K61050052 | -- | -- | -- | Details |
| C21813 | BRD-K61050695 | BRD-K61050695 | -- | -- | -- | Details |
| C21814 | BRD-K61051532 | BRD-K61051532 | -- | -- | -- | Details |
| C21815 | BRD-K61052964 | BRD-K61052964 | -- | -- | -- | Details |
| C21816 | BRD-K61053165 | BRD-K61053165 | -- | -- | -- | Details |
| C21817 | BRD-K61053657 | BRD-K61053657 | -- | -- | -- | Details |
| C21818 | BRD-K61059900 | BRD-K61059900 | -- | -- | -- | Details |
| C21819 | BRD-K61065740 | BRD-K61065740 | -- | -- | -- | Details |
| C21820 | BRD-K61070477 | BRD-K61070477 | -- | -- | -- | Details |
| C21821 | BRD-K61072684 | BRD-K61072684 | -- | -- | -- | Details |
| C21822 | BRD-K61076106 | BRD-K61076106 | -- | -- | -- | Details |
| C21823 | BRD-K61078510 | BRD-K61078510 | -- | -- | -- | Details |
| C21824 | BRD-K61079130 | BRD-K61079130 | -- | -- | -- | Details |
| C21825 | BRD-K61082257 | BRD-K61082257 | -- | -- | -- | Details |
| C21826 | BRD-K61083743 | BRD-K61083743 | -- | -- | -- | Details |
| C21827 | BRD-K61087440 | BRD-K61087440 | -- | -- | -- | Details |
| C21828 | BRD-K61092554 | BRD-K61092554 | -- | -- | -- | Details |
| C21829 | BRD-K61097567 | SB-218795 | TACR3 | Tachykinin antagonist | -- | Details |
| C21830 | BRD-K61102114 | BRD-K61102114 | -- | -- | -- | Details |
| C21831 | BRD-K61102260 | BRD-K61102260 | -- | -- | -- | Details |
| C21832 | BRD-K61105081 | BRD-K61105081 | -- | -- | -- | Details |
| C21833 | BRD-K61106942 | BRD-K61106942 | PKM | Pyruvate kinase isozyme activator | -- | Details |
| C21834 | BRD-K61113746 | BRD-K61113746 | -- | -- | -- | Details |
| C21835 | BRD-K61122325 | BRD-K61122325 | -- | -- | -- | Details |
| C21836 | BRD-K61123818 | BRD-K61123818 | -- | -- | -- | Details |
| C21837 | BRD-K61124142 | BRD-K61124142 | -- | -- | -- | Details |
| C21838 | BRD-K61127355 | BRD-K61127355 | -- | -- | -- | Details |
| C21839 | BRD-K61127831 | VU-0413247-1 | -- | -- | -- | Details |
| C21840 | BRD-K61128465 | mdivi-1 | DNM1 | Dynamin inhibitor | MDIVI-1 | Details |
| C21841 | BRD-K61134709 | BRD-K61134709 | -- | -- | -- | Details |
| C21842 | BRD-K61139423 | BRD-K61139423 | -- | -- | -- | Details |
| C21843 | BRD-K61144709 | BRD-K61144709 | -- | -- | -- | Details |
| C21844 | BRD-K61148205 | BRD-K61148205 | -- | -- | -- | Details |
| C21845 | BRD-K61152698 | BRD-K61152698 | -- | -- | -- | Details |
| C21846 | BRD-K61158263 | BRD-K61158263 | -- | -- | -- | Details |
| C21847 | BRD-K61160172 | BRD-K61160172 | -- | -- | -- | Details |
| C21848 | BRD-K61161989 | BRD-K61161989 | -- | -- | -- | Details |
| C21849 | BRD-K61164584 | BRD-K61164584 | -- | -- | -- | Details |
| C21850 | BRD-K61164776 | BRD-K61164776 | -- | -- | -- | Details |
| C21851 | BRD-K61168922 | BRD-K61168922 | -- | -- | -- | Details |
| C21852 | BRD-K61168987 | BRD-K61168987 | -- | -- | -- | Details |
| C21853 | BRD-K61172568 | BRD-K61172568 | -- | -- | -- | Details |
| C21854 | BRD-K61175124 | BRD-K61175124 | -- | -- | -- | Details |
| C21855 | BRD-K61177364 | NBI-27914 | CRHR1 | CRF receptor antagonist | -- | Details |
| C21856 | BRD-K61181530 | BRD-K61181530 | -- | -- | -- | Details |
| C21857 | BRD-K61182411 | BRD-K61182411 | -- | -- | -- | Details |
| C21858 | BRD-K61185334 | BRD-K61185334 | -- | -- | -- | Details |
| C21859 | BRD-K61189585 | BRD-K61189585 | -- | -- | -- | Details |
| C21860 | BRD-K61190439 | BRD-K61190439 | -- | -- | -- | Details |
| C21861 | BRD-K61192129 | BRD-K61192129 | -- | -- | -- | Details |
| C21862 | BRD-K61192372 | capecitabine | TYMS | DNA synthesis inhibitor; Thymidylate synthase inhibitor | -- | Details |
| C21863 | BRD-K61195623 | BRD-K61195623 | -- | -- | combretastatin-A-4 | Details |
| C21864 | BRD-K61199074 | BRD-K61199074 | -- | -- | -- | Details |
| C21865 | BRD-K61202234 | BRD-K61202234 | -- | -- | -- | Details |
| C21866 | BRD-K61206648 | BRD-K61206648 | -- | -- | -- | Details |
| C21867 | BRD-K61208213 | BRD-K61208213 | -- | -- | -- | Details |
| C21868 | BRD-K61209548 | BRD-K61209548 | -- | -- | -- | Details |
| C21869 | BRD-K61213827 | BRD-K61213827 | -- | -- | -- | Details |
| C21870 | BRD-K61217870 | BRD-K61217870 | -- | -- | N-(3-acetamidophenyl)-3-chlorobenzamide | Details |
| C21871 | BRD-K61219693 | BRD-K61219693 | -- | -- | -- | Details |
| C21872 | BRD-K61220066 | BRD-K61220066 | -- | -- | -- | Details |
| C21873 | BRD-K61220632 | leoidin | -- | -- | -- | Details |
| C21874 | BRD-K61223323 | BRD-K61223323 | -- | -- | -- | Details |
| C21875 | BRD-K61228301 | SGI-1027 | DNMT1; DNMT3A; DNMT3B | DNA methyltransferase inhibitor | -- | Details |
| C21876 | BRD-K61230716 | sodium-nitrite | -- | -- | -- | Details |
| C21877 | BRD-K61236135 | tiratricol | THRB | Thyroid hormone stimulant | -- | Details |
| C21878 | BRD-K61237522 | BRD-K61237522 | -- | -- | -- | Details |
| C21879 | BRD-K61242280 | BRD-K61242280 | -- | -- | -- | Details |
| C21880 | BRD-K61242732 | BRD-K61242732 | -- | -- | -- | Details |
| C21881 | BRD-K61247793 | BRD-K61247793 | -- | -- | -- | Details |
| C21882 | BRD-K61248029 | FU-JMBII113B | -- | -- | -- | Details |
| C21883 | BRD-K61248288 | BRD-K61248288 | -- | -- | -- | Details |
| C21884 | BRD-K61250553 | loperamide | OPRD1; OPRM1 | Opioid receptor agonist | -- | Details |
| C21885 | BRD-K61255273 | BRD-K61255273 | -- | -- | -- | Details |
| C21886 | BRD-K61255301 | BRD-K61255301 | -- | -- | -- | Details |
| C21887 | BRD-K61259788 | BRD-K61259788 | -- | -- | -- | Details |
| C21888 | BRD-K61260019 | BRD-K61260019 | -- | -- | -- | Details |
| C21889 | BRD-K61260096 | BRD-K61260096 | -- | -- | -- | Details |
| C21890 | BRD-K61268714 | BRD-K61268714 | -- | -- | -- | Details |
| C21891 | BRD-K61269089 | daphnetin | -- | -- | -- | Details |
| C21892 | BRD-K61271364 | BRD-K61271364 | -- | -- | -- | Details |
| C21893 | BRD-K61274359 | BRD-K61274359 | -- | -- | -- | Details |
| C21894 | BRD-K61278167 | BRD-K61278167 | -- | -- | -- | Details |
| C21895 | BRD-K61283064 | BRD-K61283064 | -- | -- | -- | Details |
| C21896 | BRD-K61283921 | BRD-K61283921 | -- | -- | -- | Details |
| C21897 | BRD-K61284851 | BRD-K61284851 | -- | -- | -- | Details |
| C21898 | BRD-K61285042 | BRD-K61285042 | -- | -- | -- | Details |
| C21899 | BRD-K61287439 | BRD-K61287439 | -- | -- | -- | Details |
| C21900 | BRD-K61310138 | BRD-K61310138 | -- | -- | -- | Details |
| C21901 | BRD-K61314889 | endo-IWR-1 | TNKS2 | PARP inhibitor | -- | Details |
| C21902 | BRD-K61315077 | BRD-K61315077 | -- | -- | -- | Details |
| C21903 | BRD-K61316494 | BRD-K61316494 | -- | -- | -- | Details |